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Rautiainen E, Oravainen J, Virolainen JV, Tuovinen V: Regional eradication of
Mycoplasma hyopneumoniae from pig herds and documentation of freedom of the
disease. Acta vet. scand. 2001, 42, 355-364. – The objectives of this study were to 1)
screen all sow herds in a region for M. hyopneumoniae, 2) to effectuate an eradication
programme in all those herds which were shown to be infected with M. hyopneumoniae,
and 3) to follow the success of the screening and the eradication programmes. The ulti-
mate goal was to eradicate M. hyopneumoniae from all member herds of a cooperative
slaughterhouse (153 farrowing herds + 85 farrowing-to-ﬁnishing herds + 150 spe-
cialised ﬁnishing herds) before year 2000. During 1998 and 1999, a total of 5067
colostral whey and 755 serum samples (mean, 25 samples / herd) were collected from
sow herds and analysed for antibodies to M. hyopneumoniae by ELISA. Antibodies
were detected in 208 (3.6%) samples. Two farrowing herds (1.3%) and 20 farrowing-to-
ﬁnishing herds (23.5%) were shown to be infected with M. hyopneumoniae. A pro-
gramme to eradicate the infection from these herds was undertaken. During March
2000, a survey was made to prove the success of the screening and the eradication pro-
grammes. In total, 509 serum samples were collected randomly from slaughtered ﬁn-
ishing pigs. Antibodies to M. hyopneumoniae were not detected in 506 of the samples,
whereas 3 samples were considered suspicious or positive. Accordingly, 3 herds were
shown to be infected. One of the herds was previously falsely classiﬁed as non-infected.
Two of the herds were ﬁnishing herds practising continuous ﬂow system (CF). Unlike
ﬁnishing herds which practice all-in/all-out management routines on herd level, CF
herds do not get rid of transmissible diseases spontaneously between batches, for which
reason a screening was made in the rest of the CF herds (total n = 7). Consequently, 2
more infected herds were detected. In addition to the results of the survey, a decreasing
prevalence of lung lesions at slaughter (from 5.2% to 0.1%) and lack of clinical break-
downs indicated that all member herds were ﬁnally free from M. hyopneumoniae in the
end of year 2000.
ELISA; colostrum; antibodies; all-in/all-out; lung lesions; screening; sampling; sur-
vey.
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Introduction
Mycoplasmal pneumonia of swine (swine en-
zootic pneumonia; SEP) caused by Myco-
plasma hyopneumoniae (M. hyopneumoniae) is
one of the most common and economically im-
portant diseases among pigs. Economic losses
due to SEP are often associated with secondary
infections, poor management and poor environ-
mental conditions (Ross 1999). In Finland, thenegative effect of M. hyopneumoniae infection
on mean daily gain (MDG) of ﬁnishing pigs has
been estimated to be 24 g (Tuovinen et al.
1994a) and 60 g (Rautiainen et al. 2000b). In
contrast to most other countries, M. hyopneu-
moniae is not ubiquitous in Finnish sow herds;
the prevalence varies between 8% (Tuovinen et
al. 1994b) and 30% (Rautiainen 1998) in dif-
ferent parts of the country. However, until re-
cently a majority of ﬁnishing herds have been
ﬁlled with feeder pigs some of which have been
carrying the infection (Tuovinen et al. 1994b,
Rautiainen 1998).
Finland is free from all major epidemic pig dis-
eases, so called list A diseases of OIE (Ofﬁce
International des Epizooties). In addition,
porcine reproductive and respiratory syndrome,
Aujeszky´s disease or swine inﬂuenza have
never been reported in Finland (Anon. 2000).
Furthermore, elite breeding herds are declared
free from M. hyopneumoniae and from the fol-
lowing infectious agents: Serpulina hyodysen-
teriae, toxigenic  Pasteurella multocida, Clo-
stridium perfringens type C, Sarcoptes scabiei
var suis, and all serotypes of salmonella (Anon.
1997). In order to prevent these infections in
production herds as well, health classiﬁcation
(HC) of farrowing herds followed by health
matching of multisource feeder pigs was intro-
duced in Finland in 1994 (Tuovinen et al.1996).
The producers of the health class feeder pigs re-
ceived a premium price. Feeder pigs from herds
with different health status were transported
separately. The health class pigs were given a
guarantee for freedom from M. hyopneumo-
niae.
Eradication of M. hyopneumoniae from in-
fected herds without total depopulation, i.e.
with reasonable costs, has been reported repeat-
edly (Waldmann & Radtke 1937, Zimmermann
et al. 1989, Wallgren et al. 1993b). Since the
start of HC, freedom of M. hyopneumoniae has
become an economically tempting goal for
many herds still infected with this particular in-
fectious agent, and dozens of eradication pro-
grammes have been effectuated (Tuovinen &
Heinonen 1997, Heinonen et al. 1999). 
In Britain, reinfections with M. hyopneumoniae
were shown to occur in enzootic-pneumonia-
free pig herds without simple explanations
and in spite of zootechnical precautions of
high standard (Goodwin 1985). Consequently,
Goodwin (1985) suspected that airborne trans-
mission of this infectious agent was possible
between neighbouring herds. This view was
later shared by others (Stärk et al. 1992, Thom-
sen et al. 1992). From this point of view, only
regional freedom from disease would effec-
tively prevent the majority of reinfections. At-
tempts to create regions free from M. hyopneu-
moniae have recently been made in 2 pig dense
areas in Switzerland (Masserey-Wullschleger &
Maurer 1998). 
The cooperative slaughterhouse Lihakunta op-
erates in Eastern and Northern Finland to sup-
ply meat for the meat packing company Atria
Ltd. In 1999, a total of 156000 pigs were
slaughtered which corresponded to about 7% of
the national production. A typical specialised
ﬁnishing herd of the region comprises 200-300
pigs located in one unit and practises all-in/all-
out management routines. The ﬁnishers (York-
shire x Landrace) generally originate from 15 to
20 different piglet producing herds and arrive at
the weight of approximately 25 kg. The overall
pig density is considered low. 
In 1995, a preliminary survey was made to get
an overview of the prevalence of M. hyopneu-
moniae in the farrowing herds of Lihakunta.
During one week, 41 blood samples were col-
lected from slaughter pigs of 7 randomly cho-
sen ﬁnishing herds. These samples were anal-
ysed for antibodies to M. hyopneumoniae with
an ELISA described in the chapter Materials
and methods. Antibodies were not detected in 4
of the herds, whereas in the remaining 3 herds
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ples indicating M. hyopneumoniae infection in
those ﬁnishing herds. Thus, according to the
survey, pigs in roughly one half of the ﬁnishing
herds were infected with M. hyopneumoniae.
Still, the prevalence of piglet producing farrow-
ing herds which were transmitting the infection
to the ﬁnishing herds could have been as low as
4-5 percentages. The following formula was
used in the calculations (Snedecor & Cochran
1980):
P = 1 – (1 – p)N
where P (0.50) is the probability of a ﬁnishing
herd to get infected pigs from the source herds;
N (15) is the average no. of the source herds per
batch of ﬁnishers; p is the prevalence of the
source herds infected with M. hyopneumoniae.
The objectives of this study were to screen all
farrowing and farrowing-to-ﬁnishing herds of
Lihakunta for M. hyopneumoniae; to effectuate
an eradication programme in all those herds
which were shown to be infected with M. hyop-
neumoniae; to follow the success of the screen-
ing and the eradication programmes. The ulti-
mate goal was to eradicate M. hyopneumoniae
from all member herds of Lihakunta before
year 2000 (including specialised ﬁnishing
herds).
Materials and methods
The member pig herds of Lihakunta
The number of farrowing and farrowing-to-ﬁn-
ishing herds in this study was 153 and 85, re-
spectively, and the number of specialised ﬁn-
ishing herds was 150. The median number of
sows per herd was 38 (range, 1-120), and the
median number of ﬁnishing pigs per herd was
300 (range, 50-1800). 
Screening for the health status
During 1998 and 1999, all sow herds were as-
sumed to document their health status concern-
ing M. hyopneumoniae. The health status was
veriﬁed serologically using either sow colo-
strum samples (Rautiainen et al. 2000a) or
blood samples mainly from ﬁnishing pigs col-
lected at slaughter. The expected number of
samples was 30 (or the corresponding no. of
sows in herds with less than 30 sows). With this
sample size, it was possible to detect at least
one sample with antibodies with 99% conﬁ-
dence, if the prevalence of positive samples was
at least 10% (Cannon & Roe 1982). The costs
for the analyses were paid by the slaughter-
house company.
If antibodies to M. hyopneumoniaewere not de-
tected in the collected samples, a herd was clas-
siﬁed as non-infected. If, on the other hand, an-
tibodies were detected, additional clinical
inspections were made by the local veterinar-
ian. If respiratory signs (cough in weaners and
young ﬁnishers) and/or substantial number of
lung lesions at slaughter were detected, the herd
was classiﬁed as infected. Such herds were pro-
vided an eradication plan by the slaughterhouse
company for free. If, on the other hand, no con-
ﬁrmatory signs indicating M. hyopneumoniae
infection were detected, additional blood sam-
ples were collected from pigs aged 10 weeks or
more (Wallgren et al. 1998) to detect serum an-
tibodies to M. hyopneumoniae in growing pigs.
If antibodies were not detected in those sam-
ples, herds were classiﬁed as non-infected
(false-positive herds). In specialised ﬁnishing
herds, no screening was performed because the
health status of such herds was dependant on
that of the piglet producing herds. 
Colostrum samples
Colostrum samples without additives were col-
lected by the herd managers into 10 ml plastic
tubes. The samples were collected during far-
rowing or as soon as possible after that. The
samples were stored in home freezers (-18°C).
Batches of 15 to 30 samples, wrapped in paper
and packed in card board boxes, were sent to the
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at the laboratory within 24 h from the sending. 
Blood samples
The blood samples from pigs over 10 weeks of
age were collected from vena cava cranialis
(pigs up to 35 kg of weight) or vena jugularis
dexter (pigs >35 kg of weight) using evacuated
glass tubes without additive. The samples were
collected by the local practitioners or by the
second or third author. The samples were sent
to the laboratory on the same day as collected
without separation of serum. At the slaughter-
house, blood samples were collected from ﬁn-
ishing pigs at exsanguination. All samples were
refrigerated without separating the serum. A
batch of samples was sent to the laboratory
daily or every second or third day.
Detection of antibodies to M. hyopneumoniae
Before the analysis, all colostrum samples were
treated as described earlier (Rautiainen et al.
2000b). The colostral whey (diluted 1:10 in
sample diluent) was analysed by a monoclonal
blocking-ELISA (Mycoplasma hyopneumoniae
ELISA®, DAKO, Glostrup, Denmark) in single
wells to detect antibodies to M. hyopneumo-
niae. ELISA results were expressed as percent-
ages of blocking of the monoclonal antibody
used in the assay. A sample with a blocking-
value over 50% at 492 nm wave length was
retested in duplicate wells and then classiﬁed as
having antibodies (positive), if the blocking-
value still exceeded 50%. All other samples
were classiﬁed as negative. At the cut-off value
of 50 %, the sensitivity and the speciﬁcity of the
ELISA (with 95% conﬁdence intervals) have
been reported to be 100% (98% to 100%) and
100% (93% to 100%), respectively (Sørensen et
al. 1997).
The blood samples were centrifuged 3500 × g
for 10 min and the sera were analysed similarly
as the colostral whey samples with one excep-
tion: Samples with a blocking-value between
35% and 50% were classiﬁed as suspected, and
the corresponding herds were treated similarly
as the herds giving positive results.
Eradication programmes and the follow-up
The eradication programmes for individual
herds were planned by a consulting veterinarian
of the slaughterhouse Lihakunta in collabora-
tion with the local practitioners and the herd
owners. The programmes were based on re-
moval of the young animals from the herds and
medication of the breeding stock (Waldmann &
Radtke 1937, Zimmermann et al. 1989, Wall-
gren et al. 1993b). In addition, medication for
the eradication of Sarcoptes scabiei var suis,
the causative agent of sarcoptic mange, was
given to the breeding stock in several herds ac-
cording to Hogg (1989). The eradication of M.
hyopneumoniae from specialised ﬁnishing
herds was based on the assumption that the in-
fectious agent will not survive in the environ-
ment between 2 batches of pigs (Goodwin
1985), when all-in/all-out management rou-
tines are practised at herd level.
To follow the success of the programme in an
individual herd, 15-20 blood samples were col-
lected for the detection of antibodies to M.
hyopneumoniae. The target group for sampling
were pigs born after the effectuation of the pro-
gramme and aged from 10 weeks to 6 months.
The sample size was convenient, since it often
happened that the number of pigs of the right
age group was very limited at the time when the
ﬁrst pigs borne after the eradication programme
were ready to be sold to specialised ﬁnishing
herds. In addition to serology, the absence of
both cough during rearing and lung lesions in-
dicating SEP detected at slaughter were used as
indicators of freedom from M. hyopneumoniae
in ﬁnishing herds. Lung lesions were reported
continuously for all member herds by the meat
inspection team. 
358 E. Rautiainen et al.
Acta vet. scand. vol. 42 no. 3, 2001Survey to detect antibodies in ﬁnishing pigs at
slaughter
In order to follow the success of the screening
and eradication programmes, a survey was car-
ried out during March 2000 to detect antibodies
to M. hyopneumoniae in ﬁnishing pigs of Li-
hakunta (including pigs from both farrowing-
to-ﬁnishing herds and all kinds of specialised
ﬁnishing herds). The monthly number of
slaughtered ﬁnishing pigs was about 15000.
With a sample size of 459 (Cannon and Roe
1982), it was possible to detect at least one pos-
itive sample with 99% conﬁdence, if the preva-
lence of positive samples was at least 1%. Thus,
to get a total of 500 samples a blood sample was
collected systematically from every 30th pig.
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Table 1. Pig herds of cooperative slaughterhouse Lihakunta with antibodies to Mycoplasma hyopneumoniae
and which were later shown to be infected with the agent. The time of eradication of the agent is shown, too.
No. of colostral whey Time of The follow-up serum
Herd No. of Production or serum samples eradication samples after eradication
sows type positiveb total (month/year) positiveb total Notes
Kar 24 B 5 18 - - - ﬁnished all production
Lin 15 A 18 28a - - - turned to ﬁnishing herd
Mäk 14 A 3 15a - - - resigned membership
Tuo 28 B 11 24 9 / 98 0 20
Pie 48 A 4 30 12 / 98 0 20
Hei 50 A 9 28a 4 / 99 0 25
Rah 46 A 25 30 4 / 99 0 30
Mie 30 A 5 15 5 / 99 0 15
Mar 25 A 8 10 5 / 99 0 20
Kär 19 A 4 15 5 / 99 0 20
OjH 30 A 11 20 6 / 99 0 10
OjR 30 A 8 16 6 / 99 n.a. n.a. n.a. = not analysed
Eur 170 A 7 12a 7 / 99 0 20
Ant 35 A 13 18 8 / 99 0 11
Kej 20 A 18 20 9 / 99 0 20
Par 25 A 9 11a 9 / 99 0 11
Vou 38 A 8 21 9 / 99 0 15
Meh 26 A 13 19 12 / 99 0 10
Oll 10 A 6 15 12 / 99 n.a. n.a.
Pak 12 A 6 10a 12 / 99 0 16
Ras 60 A 5 23a 12 / 99 0 11
Ten 25 A 14 29a 12 / 99 0 10
Tas 20 Ac 81 5 a 9 / 00 n.a. n.a.
Aht - Cc 81 0 a 6 / 00 - -
Tur - Cc 77 a 7 / 00 - -
Vit - Cc 17 a 7 / 00 - -
Kol - Cc 91 5 a 11 / 00 - -
All sow herds were screened for M. hyopneumoniae antibodies during 1998 and 1999. In addition, a survey of all pig herds was
done in March 2000 based on randomly collected blood samples (n=509) from slaughtered ﬁnishing pigs. Simultaneously, all
type C herds were screened.
A = farrowing-to-ﬁnishing herd; B = farrowing herd; C = ﬁnishing herd practising continuous ﬂow system
a Serum samples b Corresponding to antibodies to M. hyopneumoniae by ELISA. c Indication of infection was found only
during the survey or the screening of type C herds.Statistical analysis
The prevalence of lung lesions detected at
slaughter was recorded quarterly during 1998-
2000. The analysis of trend was made using
Pearson correlation for continuous data. The
programme used in the analyses was Statistix




During 1998 and 1999, a total of 5067 colostral
whey samples and 755 serum samples (mean,
25 samples / herd) were analysed for antibodies
to M. hyopneumoniae by ELISA. Antibodies
were detected in 208 samples (3.6%). Two far-
rowing herds (1.3%) and 20 farrowing-to-ﬁn-
ishing herds (23.5%) were shown to be infected
with M. hyopneumoniae (Table 1, Fig. 1). In ad-
dition, single positive samples were detected in
11 herds, however, without any other ﬁndings
indicating M. hyopneumoniae infection accord-
ing to the additional inspections and blood sam-
ples. These herds were classiﬁed as non-in-
fected false-positive herds. In all, only few
herds were unwilling to cooperate with the
screening. Samples from such herds were en-
tirely collected at the slaughterhouse.
Eradication programmes
One owner of a herd infected with M. hyopneu-
moniae refused to eradicate the infection and
resigned the membership. One herd ﬁnished
pig production and another one changed the
production type from integrated to fattening
(Table 1). In the remaining herds, an eradica-
tion programme was effectuated according to
the timetable shown in Table 1. Antibodies to
M. hyopneumoniae have not been detected in
any of the follow-up samples (n=284) taken in
the herds after the completion of the eradication
programmes (Table 1). Nor have any clinical or
pathological ﬁndings indicated failures of the
eradication programmes so far (February
2001).
Survey to detect antibodies in ﬁnishing pigs at
slaughter
A total of 509 serum samples were collected.
Antibodies to M. hyopneumoniae were not de-
tected in 506 samples (99.4%). Two samples
were considered positive and one sample suspi-
cious. These 3 samples were traced back to 3
different herds and, according to additional in-
spections, all herds were shown to be infected
with M. hyopneumoniae. Two of these herds
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Figure 1. A map of Finland showing the regional
distribution of member pig herds of cooperative
slaughterhouse Lihakunta which were shown to be
infected with Mycoplasma hyopneumoniae (marked
with stars).were ﬁnishing herds practising a continuous
ﬂow system. The third one was a farrowing-to-
ﬁnishing herd (no. of sows, 20) which had had
a single positive serum sample already in the
screening test in autumn 1999, but was during
that time classiﬁed as a false-positive herd.
None of these 3 herds had sold live animals to
any other herds.
It appeared during the survey that the health
status of ﬁnishing herds practising a continuous
ﬂow system was unknown. Therefore, all such
ﬁnishing herds were identiﬁed (n=7) and their
health status was veriﬁed serologically. Conse-
quently, antibodies to M. hyopneumoniae were
detected in 4 out of 7 herds. These infected
herds were emptied, cleaned and disinfected af-
ter which all-in/all-out management routines
were implemented.
Lung lesions at slaughter
The quarterly prevalence of lung lesions of all
slaughtered pigs decreased from 5.2 % in 1998
to 0.1% in 2000 (Fig. 2). The decreasing trend
was statistically signiﬁcant (r = - 0.96; p <0.001;
n=12).
Discussion
The number of farrowing herds shown to be in-
fected with M. hyopneumoniaewas small as ex-
pected according to the pilot study. Thus, this
ﬁnding together with that of the pilot study
clearly visualised the experience that mixing of
young feeder pigs of different health status can
be disastrous for a large number of herds even
if the number of animals carrying the infectious
agent is small. On the other hand, by focusing
the preventive measures towards just a rela-
tively small number of herds (the infected far-
rowing herds) it was possible to improve the
health status of numerous ﬁnishing herds.
On the contrary, altogether every fourth of far-
rowing-to-ﬁnishing herds was shown to be in-
fected with M. hyopneumoniae. This, together
with the ﬁnding that more than one half of ﬁn-
ishing herds practising continuous ﬂow system
were infected, expressed the vulnerability of
continuous ﬂow systems in relation to transmis-
sible infectious diseases. These types of herds
made a constant risk for M. hyopneumoniae in-
fection to other herds through animal transport,
temporary selling of feeder pigs, and close
neighbourhood to some herds. Consequently,
ﬁnding out health status of such herds and erad-
ication of M. hyopneumoniae from infected
ones turned out to be the most essential activity
in this study. 
To follow the success of the screening and the
eradication programmes, a survey was per-
formed aiming at ﬁnding even a low prevalence
of disease. Following measures were taken to
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Figure 2. The quarterly prevalence of lung lesions of all slaughtered pigs during 1998-2000.increase the probability of detecting positive
samples: The test used was shown to be very
sensitive (Sørensen et al. 1997); Slaughter pigs
were chosen to be target group for sampling be-
cause of high prevalence of antibodies in this
age group (Wallgren et al. 1993a; Yagihashi et
al. 1993, Morris et al. 1995, Rautiainen et al.
2000b) and the fact that they represented the in-
fectious status of all the source herds of the ﬁn-
ishing herds; The size of the random sample
was aimed to detect at least 1% prevalence
(Cannon & Roe 1982); To reduce clustering of
the samples, the sampling was prolonged to
several weeks. The 2 positive samples and the
one suspicious sample detected during the sur-
vey could all be traced back. It appeared that
they were, indeed, indications of an endemic M.
hyopneumoniae infection in 3 particular herds
which, however, had not been selling live ani-
mals to other herds. In addition to these ﬁnd-
ings, one more screening was made in the rest
of the specialised ﬁnishing herds, which prac-
tised continuous ﬂow system, in order to ﬁnd all
potential residual infections of M. hyopneumo-
niae(2 more infected herds were found). On the
other hand, the 506 negative samples (99.4%)
indicated that the overall prevalence of M. hy-
opneumoniae had been reduced to a minimum,
perhaps even to zero. That trend was also ex-
pected from the signiﬁcant reduction of lung le-
sions to around 0.1%, since high lung lesion
prevalences have been shown to be highly de-
pendant on M. hyopneumoniae infection in Fin-
land (Tuovinen et al. 1994a, Rautiainen et al.
2000b). In addition, it is important to notice that
clinical breakdowns entitling to compensations
in ﬁnishing herds have not been reported. Con-
sequently, all these ﬁndings support the idea of
success of the programme. However, only the
near future will conﬁrm the ultimate success,
since some of the eradication programmes and
the screening tests had taken place only very re-
cently. Latent infections were considered hav-
ing caused several breakdowns in the regional
eradication programmes in Switzerland (Mas-
serey-Wullschleger & Maurer 1998).
The apparent success of the programme was
seen in daily gain, too, as expected. During
1998-2000 the mean daily gain increased from
799 g to 875 g in specialised ﬁnishing herds
(n=150, according to slaughterhouse records,
not shown in the results). This increase is in the
same magnitude as in an earlier study (Rauti-
ainen et al. 2000b). However, in addition to the
effect of M. hyopneumoniae freedom, also the
effect of freedom from sarcoptic mange was
within the ﬁgures of the present study.
During the survey, it appeared that one farrow-
ing-to-ﬁnishing herd, which had had a single
positive serum sample of a ﬁnishing pig in the
screening had been falsely classiﬁed as non-in-
fected. It is known from earlier studies that
problems in making a deﬁnitive diagnosis may
arise with sub-populations of animals in indi-
vidual herds with low pathogen load (Clark et
al. 1991, Lindahl & Wallgren 1997, Rautiainen
& Wallgren 2000). However, in an earlier sur-
vey, which covered 530 herds and was based on
colostrum samples, no such problems existed
(Rautiainen et al. 2000a), which expressed the
superiority of colostrum samples for the
screening of herds. The reason for the high sen-
sitivity of colostrum samples is that when the
pathogen load in a herd is low, sows have a
longer period than ﬁnishing pigs to develop hu-
moral immune response to M. hyopneumoniae
which, in addition, is known to persist even for
years (Rautiainen et al. 2000a).
Only a few member herds raised opposition to
the screening of health status. The good moti-
vation of the others can be seen as a result of the
following modes of action: Veterinary consul-
tation to the herd owners concerning eradica-
tion programmes was free of charge, as was the
analysis of the samples; The ﬁeld trial had well-
deﬁned epidemiological and economical tar-
362 E. Rautiainen et al.
Acta vet. scand. vol. 42 no. 3, 2001gets, which were openly declared; Respect was
paid to the good collaboration between the local
practising veterinarians and the slaughterhouse
company. Many of these principles were
stressed already by Waldmann & Radtke
(1937), and later by Masserey-Wullschleger &
Maurer (1998).
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Sammanfattning
Regional sanering av Mycoplasma hyopneumoniae
från svinbesättningar och dokumentation av sjuk-
domsfriheten.
Syftet för denna undersökning var 1) att analysera
(fastställa) infektionsstatus gällande M. hyopneumo-
niae i alla suggbesättningar i en region, 2) att sanera
varje besättning som bedöms vara infekterad med M.
hyopneumoniae, 3) att följa analysernas och sane-
ringarnas framgång. Det slutgiltiga målet var att
utrota M. hyopneumoniae från alla medlemsbesätt-
ningar av ett andelsslakteri (153 smågrisproduce-
rande besättningar + 85 integrerade besättningar +
150 specialiserade slaktsvinsbesättningar) före år
2000. Under år 1998 och 1999 analyserades totalt
5067 råmjölksprov samt 755 serumprov (i medeltal
25 prov/besättning) för antikroppar mot M. hyopneu-
moniaemed ELISA. Antikroppar konstaterades i 208
prov (3.6%). Två smågrisproducerande besättningar
(1.3%) och 20 integrerade besättningar (23.5%) be-
dömdes vara infekterade med M. hyopneumoniae.
För dessa besättningar planerades och genomfördes
ett saneringsprogram. I mars år 2000 kartlades analy-
sernas och saneringarnas framgång. Totalt undersök-
tes (analyserades) 509 slumpmässigt tagna serum-
prov från slaktsvin. Antikroppar mot M. hyop-
neumoniae konstaterades inte i 506 prov, men tre
prov bedömdes vara positiva eller svagt positiva. Det
visade sig att 3 besättningar faktiskt var infekterade
med M. hyopneumoniae. En av besättningarna visade
sig vara en integrerad besättning, som tidigare felak-
tigt bedömts vara icke-infekterad. Två av besättning-
arna var slaktsvinsbesättningar med kontinuerlig
produktion (KP). I motsats till slaktsvinsbesättning-
arna med all-in/all-out produktion på besättningsni-
vån, blir KP besättningarna inte spontant fria från
smittsamma sjukdomarna mellan uppfödningspar-
tier. Därför analyserades infektionsstatus också i res-
ten av KP besättningarna (total n = 7). Sålunda kon-
staterades ännu 2 infekterade besättningar. Resultatet
av kartläggningen tillsammans med en förminskning
av prevalensen av lungskador vid slakt (från 5.2% till
0.1%) samt brist på kliniska sjukdomsutbrott tyder
på, att alla besättningar var slutligt fria från M.
hyopneumoniae i slutet av år 2000.
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